Better lung cancer treatment through biomarkers
How ATR-FTIR spectroscopy could lead to less invasive cancer prescreening
Preanalytical variability can be a hidden danger in skewing test results. What's the best way to detect and overcome it?
Machine learning and DNA methylation could open up a new realm of diagnostic possibility
Testing the whole population of women for breast/ovarian cancers mat be more cost-effective than current methods
Obi Griffith and Heidi Rehm
It's important to research relevant academic papers, but it's equally important to make sure it's still relevant
The story behind an inflatable pill and a sensitive biomarker that pair up to improve screening for Barrett’s esophagus – and help prevent a highly aggressive cancer
Suneel Deepak Kamath
Is direct-to-consumer testing anywhere near as useful as it appears to the public – or to science?
Can an oral fluid assay for HIV be as sensitive as a blood test?
A woman who can identify people with Parkinson’s by smell is helping scientists pinpoint molecules
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.